BioPharm International-05-01-2003

by  Wolfgang Winter, Agilent Technologies GmbH and  Ludwig Huber, Agilent Technologies GmbH  The rules for electronic records and signatures still remain in effect. The change means that companies must now justify their decisions on whether or not to implement specific electronic controls with documented risk assessments and considerations of the record requirements detailed in the corresponding predicate rule.